These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4686516)

  • 1. Dextran 40 in the treatment of peripheral vascular diseases.
    Thomas JM; Silva JR
    Arch Surg; 1973 Feb; 106(2):138-41. PubMed ID: 4686516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravascular disseminated coagulation syndrome during treatment with dextran 40].
    Wlodarczyk J; Kotschy M; Janukowiez-Lorenz H; Kurzawska M; Prastowski W; Rychlik W
    Pol Tyg Lek; 1975 Feb; 30(7):297-9. PubMed ID: 1167691
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent low molecular weight dextran infusions in the management of ischemic skin disorders.
    Holti G
    Bibl Anat; 1973; 11():359-63. PubMed ID: 4789063
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-molecular-weight dextran in the treatment of peripheral arterial insufficiency.
    Singer A
    Lancet; 1965 Nov; 2(7421):1050-2. PubMed ID: 4159137
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous intra-arterial infusion therapy with dextran in the treatment of ischemic conditions of the extremities.
    Skalkeas G; Balas P; Katsogiannis A; Karagianakos P
    Bibl Anat; 1969; 10():158-67. PubMed ID: 5407355
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous dextran 70 infusion has protective effects on ischemia reperfusion injury of kidney: an experimental study.
    Semercioz A; Temiz MZ; Erbarut I; Izol U; Aykan S; Tuken M; Kandirali E
    Minerva Urol Nefrol; 2018 Apr; 70(2):202-210. PubMed ID: 29161807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal failure associated with low-molecular-weight dextran infusion.
    Morgan TO; Little JM; Evans WA
    Br Med J; 1966 Sep; 2(5516):737-9. PubMed ID: 5917393
    [No Abstract]   [Full Text] [Related]  

  • 8. Quiz page. Tubular epithelial injury consistent with osmotic nephrosis.
    Erdbruegger U; Thomas DB; Hladik JA
    Am J Kidney Dis; 2004 Aug; 44(2):A45, e1. PubMed ID: 15264204
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute reversible renal insufficiency after prolonged treatment with dextran].
    Fillastre JP; Mignon F; Sraer JD; Morel-Maroger L; Richet G
    Presse Med (1893); 1967 Nov; 75(50):2535-8. PubMed ID: 6075699
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study on pathogenesis of acute renal failure].
    Hirata K; Ueda T; Morita I; Hirata H; Takamatsu T
    Nihon Jinzo Gakkai Shi; 1973 May; 15(5):371-91. PubMed ID: 4797294
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute oligoanuric renal failure in dextran 40 treated patients.
    Frey L; Messmer K
    Ren Fail; 1998 May; 20(3):543-5. PubMed ID: 9606743
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs five years later: dextran 40.
    Data JL; Nies AS
    Ann Intern Med; 1974 Oct; 81(4):500-4. PubMed ID: 4606455
    [No Abstract]   [Full Text] [Related]  

  • 13. Dextran-40, acute renal failure, and elevated plasma oncotic pressure.
    N Engl J Med; 1988 Jan; 318(4):252-4. PubMed ID: 2447499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphology of renal structures in the dog after prolonged administration of Plasmacair].
    Boutet G; Labie C; Besson F
    Agressologie; 1989; 30(9-10):525-8. PubMed ID: 2483033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of iterative perfusions with low molecular weight dextran in long-term treatment of retinal venous occlusions].
    Cordier J; Raspiller A; Bowyer M; Vouters H
    Bull Soc Ophtalmol Fr; 1978 Nov; 78(11):795-9. PubMed ID: 755549
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of low molecular weight dextran in peripheral arterial disease.
    Hardy DA; Klippel AP
    Am Surg; 1969 Jul; 35(7):468-70. PubMed ID: 5785907
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experiences with the treatment of peripheral vascular diseases.
    Kowal-Gierczak B; Kurzawska-Mielecka M; Wysokiński W
    Mater Med Pol; 1986; 18(1):24-8. PubMed ID: 3528687
    [No Abstract]   [Full Text] [Related]  

  • 18. Anuric acute renal failure caused by dextran 40 administration.
    Ferraboli R; Malheiro PS; Abdulkader RC; Yu L; Sabbaga E; Burdmann EA
    Ren Fail; 1997 Mar; 19(2):303-6. PubMed ID: 9101608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV.
    Biesenbach G; Kaiser W; Zazgornik J
    Ren Fail; 1997 Jan; 19(1):69-75. PubMed ID: 9044453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dextran in severe ischemic extremity disease and arterial reconstructive surgery. A review.
    Bergqvist D; Bergentz SE
    Vasa; 1983; 12(3):213-8. PubMed ID: 6195843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.